LAURA KIGHT: Open Payments
NPI 1205351137 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,026 in 112 payments from 13 companies in 2025. Trend: 2023 $2,256 · 2024 $1,556 · 2025 $3,026
Food & beverage: $3,021Education: $5
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 18 | $496 |
| Vanda Pharmaceuticals Inc. | 17 | $482 |
| Janssen Pharmaceuticals, Inc | 14 | $456 |
| ABBVIE INC. | 12 | $345 |
| E.R. Squibb & Sons, L.L.C. | 4 | $260 |
| Alkermes, Inc. | 12 | $253 |
| Axsome Therapeutics, Inc. | 9 | $210 |
| Indivior Inc. | 13 | $201 |
| Neurocrine BioSciences, Inc. | 4 | $192 |
| Corium, LLC | 6 | $71 |
Products named: BRIXADI, FANAPT, SPRAVATO, VRAYLAR, COBENFY, Auvelity, SUBLOCADE, INGREZZA.
Industry payments across LA — which companies pay providers there.
